Drug Trial Radar · NCT07931495
A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Diet and Exercise
Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
200
Planned (sponsor's estimate)
Start
Nov 10, 2026
Primary completion
Jun 5, 2028
Study completion Aug 28, 2028
Sponsor
- Lead sponsor
- Novo Nordisk A/SNovo Nordisk (NVO)
- Sponsor type
- Industry
- First posted
- Nov 12, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is being done to look at how well zenagamtide lowers blood sugar levels and body weight in people with type 2 diabetes when compared to placebo. Participants will either get zenagamtide, the treatment being tested or placebo, a treatment that has no active medicine in it. Which treatment participants get is decided by chance. Zenagamtide is a new medicine that doctors cannot prescribe yet, but it has been tested in humans before.
Conditions
- Diabetes Mellitus, Type 2
Interventions
ZenagamtideDrug
Zenagamtide will be administered subcutaneously once weekly.
PlaceboDrug
Placebo matched to zenagamtide will be administered subcutaneously once weekly.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in glycated haemoglobin (HbA1c)Time frame: From baseline (week 0) to week 44
Locations
48 sites in 8 countries. Site status is shown where the registry gives one.
Ark Clinical Research
Fountain Valley, California
Los Angeles Institute for Metabolic Research
Los Angeles, California
Encompass Clinical Research_Spring Valley
Spring Valley, California
Encore Medical Research LLC
Hollywood, Florida
My Preferred Research
Miami, Florida
Florida Institute for Clinical research
Orlando, Florida
Encore Medical Research of Weston
Weston, Florida
Brigham & Women's Hospital
Boston, Massachusetts
Accellacare
Wilmington, North Carolina
Preferred Primary Care physicians Washington
Washington, Pennsylvania
Southwest Clinical Trials
Houston, Texas
Pinnacle Clinical Research
San Antonio, Texas
Chongqing University Three Gorges Hospital-Endocrinology
Chongqing, Chongqing Municipality, China
The Second Affiliated Hospital of Nanjing Medical University-Endocrinology
Nanjing, Jiangsu, China
The Affiliated Hospital of Jiangsu University-Endocrinology
Zhenjiang, Jiangsu, China
Jinan Central Hospital-General Medicine
Jinan, Shandong, China
Tianjin Medical University Chu Hsien-I Memorial Hospital-Department of Metabolism
Tianjin, Tianjin Municipality, China
Akaicho Clinic_Internal medicine
Chiba-shi, Chiba, Japan
Tokyo-Eki Center-building Clinic_Internal Medicine
Tokyo, Japan
Fukuwa Clinic_Internal Medicine
Tokyo, Japan
ToCROM Clinic_Internal Medicine
Tokyo, Japan
OCROM Clinic_Internal medicine
Suita-shi, Osaka, Japan
Pro Familia Altera Sp. z o.o.
Katowice, Poland
Centrum Badawcze Panaceum Agnieszka Brzezicka Magdalena Lenkiewicz Sp. z o.o.
Malbork, Poland
Formed 2 Sp. z o.o.
Oświęcim, Poland
Velocity Nova Sp. z o.o.
Staszów, Poland
Balticmed Świnoujście Sp. z o. o.
Świnoujście, Poland
NBR Polska Tomasz Klodawski
Warsaw, Poland
Cbk Med Clinic Sp. z o.o.
Płock, Masovian Voivodeship, Poland
Solace Clinical Research
San Juan, Puerto Rico
SC Nutrilife SRL
Bucharest, Romania
Institutul De Pneumoftiziologie Marius Nasta
Bucharest, Romania
SC Gensan SRL, Policlinica ASTRA
Sibiu, Romania
Diabdana S.R.L.
Oradea, Bihor County, Romania
Poli Cardinal Med Srl
Reghin, Mureș County, Romania
Sc Mediab Srl
Târgu Mureş, Mureș County, Romania
KARDIO-SANUS, spol. s r.o.
Bratislava, Slovakia
Diab - Int, s.r.o.
Bytča, Slovakia
Univerzitna nemocnica L. Pasteura Kosice
Košice, Slovakia
FUNKYSTUFF s.r.o
Nové Zámky, Slovakia
Showing 40 of 48 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.